Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals
Jan 18 2019
•
By
Malcolm Spicer
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Rx-to-OTC Switch
More from Health